- Revenue Cycle Management
- COVID-19
- Reimbursement
- Diabetes Awareness Month
- Risk Management
- Patient Retention
- Staffing
- Medical Economics® 100th Anniversary
- Coding and documentation
- Business of Endocrinology
- Telehealth
- Physicians Financial News
- Cybersecurity
- Cardiovascular Clinical Consult
- Locum Tenens, brought to you by LocumLife®
- Weight Management
- Business of Women's Health
- Practice Efficiency
- Finance and Wealth
- EHRs
- Remote Patient Monitoring
- Sponsored Webinars
- Medical Technology
- Billing and collections
- Acute Pain Management
- Exclusive Content
- Value-based Care
- Business of Pediatrics
- Concierge Medicine 2.0 by Castle Connolly Private Health Partners
- Practice Growth
- Concierge Medicine
- Business of Cardiology
- Implementing the Topcon Ocular Telehealth Platform
- Malpractice
- Influenza
- Sexual Health
- Chronic Conditions
- Technology
- Legal and Policy
- Money
- Opinion
- Vaccines
- Practice Management
- Patient Relations
- Careers
Spider venom could help with erectile dysfunction; New blood test for sepsis; Experimental nasal spray for rapid heartbeat - Morning Medical Update
The top news stories in primary care today.
doctor morning desk © Alena Kryazheva - stock.adobe.com
Spider venom could help with erectile dysfunction
Scientists are now using spider venom to treat erectile dysfunction. The spider of interest is the Brazilian wandering spider (also known as the banana spider) because its venom causes long-lasting, painful erections. Trials show there are no negative side effects of using the venom this way.
A new test called the IntelliSep test quickly identifies if patients have sepsis. Trials show a 95% survival rate, with a cost of less than $4,000 a patient. It is more successful than other methods, which include monitoring procalcitonin levels.
Experimental nasal spray for rapid heartbeat
A new nasal spray that may allow patients to instantly treat their rapid heartbeat may soon be available. It is currently awaiting approval from the U.S. Food and Drug Administration. Nearly 1 in 300 people in the United States suffer from rapid heartbeat.
